Skip to content

Efficacy check of skin care product

PRIMARY OBJECTIVE: To evaluate and compare the in-vivo efficacy and safety of two skin regimes in terms of reduction in dark spots (Lightens the pigmentation of selected dark spots-age spots), improvement in skin moisturization upto 48 hours, improvement in skin brightening , improvement in skin firmness, elasticity, skin radiance, skin glow, skin softness, prevention of water loss from skin (TEWL parameter) and tan reduction, reduction in fine line and wrinkles and clear skin in terms of reduction in dark spot and on healthy female subjects. SECONDARY OBJECTIVE: To evaluate the subject feedback for product efficacy in terms of clear skin (basis reduction in dark spots) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062693
Enrollment
72
Registered
2024-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Regime 1: This regime has 5 products in it, cleanser, 2 serum, 2 gel. These products will be applied on whole face once in a day for the period of 56 days. Intervention2: Regime 2: This

Sponsors

Incnut Lifestyle Retail Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Indian female subjects 2)Having dry skin. 3)Having normal skin type with Age Related Dark Spots. 4)Having dull and tanned skin.

Exclusion criteria

Exclusion criteria: 1)Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2)Having refused to give her assent by signing the consent form. 3)Taking part in another study liable to interfere with this study. 4)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 5)Having a progressive asthma (either under treatment or last fit in the last 2 years) 6)Being epileptic 7)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8)Having cutaneous hypersensitivity 9)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex 10) Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 11)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 12)Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit 13)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).

Design outcomes

Primary

MeasureTime frame
Reduction in dark spots (Lightens the pigmentation of selected dark spots-age spots), improvement in skin moisturization upto 48 hours, improvement in skin brightening , improvement in skin firmness, elasticity, skin radiance, skin glow, skin softness, prevention of water loss from skin (TEWL parameter) and tan reduction, reduction in fine line and wrinkles and clear skin in terms of reduction in dark spotTimepoint: Baseline, 48 hours, 14 days, 28 days, 56 days.

Secondary

MeasureTime frame
clear skin (basis reduction in dark spots)Timepoint: Baseline, 48 hours, 14 days, 28 days, 56 days.

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

raji@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026